However, because DPP-IV ubiquitously degrades important regulatory peptides in addition to GLP-1 [33], the use of a DPP-IV inhibitor might theoretically cause widespread deleterious biological effects
Its a popular choice because the muscle is substantial, and the area typically has fewer nerve endings, which can mean less discomfort during the injection
No fillers, binders, or excipients
Pharmacist to assure the latest IV rules are followed
Even though thats the case, there are still some pretty strong arguments for the use of GLP-1 agonists (at least in my opinion) so dont freak out just yet
While using the drug myself, I was quite aware of these possible consequences, and that awareness made everything feel temporary